Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2025-12-25 @ 3:37 AM
NCT ID:
NCT06648902
Eligibility Criteria:
Inclusion Criteria:
* metastatic renal cell carcinoma
* measurable disease based on RECIST 1.1 criteria
* systemic therapy with targeted or immunotargeted therapy
* any grade of fatigue associated with targeted or immunotargeted therapy
* ECOG PS \<2
* signed informed consent
Exclusion Criteria:
* Any treatment for fatigue
* Uncompensated hypothyroidism
* Anemia
* Pregnant or nursing
* Local and/or systemic infections requiring antibiotics or COVID-19 within 28 days prior to study entry
* Other malignancy
* Brain metastases
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06648902
Study Brief:
Protocol Section:
NCT06648902